Active-ingredient Dossier
Paclitaxel
Active-ingredient Dossier for Paclitaxel (taxane chemotherapy agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: PACLITAXEL EBEWE
- Brand: ABRAXANE
- Brand: ANZATAX
- Brand: Nab-PACLITAXEL
- Brand: PACLIALL
- Brand: PACLITAXEL
- Therapeutic area: Oncology
What is
Paclitaxel Paclitaxel is a taxane chemotherapy agent.
Australian brands containing
Paclitaxel — PACLITAXEL EBEWE — ABRAXANE — ANZATAX — Nab-PACLITAXEL — PACLIALL — PACLITAXEL — TEKNOXEL
Therapeutic areas
Paclitaxel is registered in oncology (11 brands) and complementary medicine (3 brands).
Sponsor landscape
Paclitaxel is marketed by nine sponsors including Hospira, Cipla, Accord Healthcare, KSJ Pharmatech, Abraxis BioScience, and Pfizer.
PBS and regulatory activity
One brand containing paclitaxel has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome is from 1 November 2008 and the latest AusPAR is from 13 March 2014.